Intelligence / Healthtech & medtech market map / Diagnostics and laboratory products / Clinical consumables and general diagnostics / Hospital core-lab specimen collection and handling consumables
Hospital core-lab specimen collection and handling consumables
Single-use blood-collection tubes (vacutainers), needles, holders, transfer devices, slides and smears, and specimen-handling plastics purchased by hospital laboratories and phlebotomy units to collect, transport and prepare patient samples for the assays run on the hospital's own analysers. Excludes rapid/point-of-care test kits and the assay reagents themselves.
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Hospitals (hospital laboratories, phlebotomy and specimen receiving departments)
- Buying centre
- Lab director / head of core lab, with procurement and infection-control and nursing-education sign-off; centralised IDN or GPO contracting for larger systems
- Test volume growth from ageing and chronic disease
- Hospital consolidation and centralisation of lab operations
- Reagent-rental instrument placements that lock in proprietary tube and needle formats
- Single-use and infection-prevention mandates
- Fragmented multi-brand consumable portfolios causing workflow inconsistency and retesting
- Needlestick and exposure injury risk in high-volume phlebotomy
- Specimen rejection and haemolysis rates that delay results and waste analyser capacity
- Price pressure from GPO contracts and tenders
How this was sized
Not sized yet
No source sizes this consumables-only pool. Bottom-up framing only: hospital laboratories were 49.3% of the worldwide laboratory diagnostics market in 2025, which was USD 110.85bn [8], i.e. roughly USD 54.6bn of hospital-lab diagnostics spend. Applying a stated consumables share of 10-15% of hospital-lab diagnostics spend (blood tubes, needles, slides, plastics are a minority of the reagent/instrument mix) gives a hospital-lab consumables pool of roughly USD 5.5-8.2bn, i.e. USD 5,500-8,200m. Arithmetic: 110.85bn x 49.3% = 54.65bn; x 10-15% = 5.5-8.2bn. Confidence Low: the 10-15% consumables share is an assumption, not a sourced figure, and the source market definitions differ (reagents+consumables+instruments vs. tests).
- Laboratory Diagnostics Market 2026 – PW Consulting
pmarketresearch.com · 2026-06-02
Alongside it in Clinical consumables and general diagnostics
// Sell into Hospital core-lab specimen collection and handling consumables